Clinical Trial Update: Nalmefene, Baclofen and Impulsivity in Subjects With Alcohol Use Disorder and Healthy Control Subjects [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating nalmefene and baclofen effects on impulsivity in adults with alcohol use disorder and healthy controls has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder

Drugs mentioned

• BACLOFEN (Baclofen)
• Nalmefene (nalmefene)

Snippet

Sponsor: Prof. Daniele Zullino | Conditions: Alcohol Use Disorder | Phase 2 | Status: COMPLETED